Your browser doesn't support javascript.
loading
Lentiviral interferon: A novel method for gene therapy in bladder cancer.
Mokkapati, Sharada; Narayan, Vikram M; Manyam, Ganiraju C; Lim, Amy H; Duplisea, Jonathan J; Kokorovic, Andrea; Miest, Tanner S; Mitra, Anirban P; Plote, Devin; Anand, Selvalakshmi Selvaraj; Metcalfe, Michael J; Dunner, Kenneth; Johnson, Burles A; Czerniak, Bogdan A; Nieminen, Tiina; Heikura, Tommi; Yla-Herttuala, Seppo; Parker, Nigel R; Schluns, Kimberley S; McConkey, David J; Dinney, Colin P.
Afiliación
  • Mokkapati S; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Narayan VM; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Manyam GC; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Lim AH; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Duplisea JJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Kokorovic A; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Miest TS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Mitra AP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Plote D; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Anand SS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Metcalfe MJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Dunner K; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Johnson BA; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Czerniak BA; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Nieminen T; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Heikura T; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • Yla-Herttuala S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Parker NR; Middlesex, Hamesman, Ltd., Edgware, London, UK.
  • Schluns KS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
  • McConkey DJ; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA.
  • Dinney CP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
Mol Ther Oncolytics ; 26: 141-157, 2022 Sep 15.
Article en En | MEDLINE | ID: mdl-35847448
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos